Ocuphire Pharma Return on Investment 2010-2024 | IRD
Current and historical return on investment (ROI) values for Ocuphire Pharma (IRD) over the last 10 years.
Ocuphire Pharma ROI - Return on Investment Historical Data |
Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
2024-06-30 |
$-0.02B |
|
inf% |
2024-03-31 |
$-0.01B |
|
inf% |
2023-12-31 |
$-0.01B |
|
inf% |
2023-09-30 |
$-0.01B |
|
inf% |
2023-06-30 |
$-0.02B |
|
inf% |
2023-03-31 |
$-0.02B |
|
inf% |
2022-12-31 |
$-0.02B |
|
inf% |
2022-09-30 |
$-0.02B |
|
inf% |
2022-06-30 |
$-0.02B |
|
inf% |
2022-03-31 |
$-0.02B |
|
inf% |
2021-12-31 |
$-0.02B |
|
inf% |
2021-09-30 |
$-0.03B |
|
inf% |
2021-06-30 |
$-0.03B |
|
inf% |
2021-03-31 |
$-0.02B |
|
inf% |
2020-12-31 |
$-0.02B |
|
inf% |
2020-09-30 |
$-0.00B |
|
inf% |
2020-06-30 |
$-0.00B |
|
inf% |
2020-03-31 |
$-0.00B |
|
inf% |
2019-12-31 |
$-0.00B |
|
inf% |
2019-09-30 |
$-0.01B |
|
inf% |
2019-06-30 |
$-0.02B |
|
inf% |
2019-03-31 |
$-0.02B |
|
inf% |
2018-12-31 |
$-0.02B |
|
inf% |
2018-09-30 |
$-0.02B |
|
inf% |
2018-06-30 |
$-0.02B |
|
inf% |
2018-03-31 |
$-0.02B |
|
inf% |
2017-12-31 |
$-0.02B |
|
inf% |
2017-09-30 |
$-0.02B |
|
inf% |
2017-06-30 |
$-0.02B |
|
inf% |
2017-03-31 |
$-0.02B |
|
inf% |
2016-12-31 |
$-0.02B |
|
inf% |
2016-09-30 |
$-0.02B |
|
inf% |
2016-06-30 |
$-0.02B |
|
inf% |
2016-03-31 |
$-0.02B |
|
inf% |
2015-12-31 |
$-0.02B |
|
inf% |
2015-09-30 |
$-0.02B |
|
inf% |
2015-06-30 |
$-0.02B |
|
inf% |
2015-03-31 |
$-0.02B |
|
inf% |
2014-12-31 |
$-0.01B |
|
inf% |
2014-09-30 |
$-0.01B |
|
inf% |
2014-06-30 |
$-0.01B |
|
inf% |
2014-03-31 |
$-0.01B |
|
inf% |
2013-12-31 |
$-0.01B |
|
inf% |
2013-09-30 |
$-0.01B |
|
inf% |
2013-06-30 |
$-0.01B |
|
inf% |
2013-03-31 |
$-0.01B |
|
inf% |
2012-12-31 |
$-0.01B |
|
inf% |
2012-09-30 |
$-0.01B |
|
inf% |
2012-06-30 |
$-0.01B |
|
inf% |
2012-03-31 |
$-0.01B |
|
inf% |
2011-12-31 |
$-0.02B |
|
inf% |
2011-09-30 |
$-0.02B |
|
inf% |
2011-06-30 |
$-0.02B |
|
inf% |
2011-03-31 |
$-0.01B |
|
inf% |
2010-12-31 |
$-0.01B |
|
inf% |
2010-09-30 |
$-0.01B |
|
inf% |
2010-06-30 |
$-0.01B |
|
inf% |
2010-03-31 |
$-0.01B |
|
inf% |
2009-12-31 |
$-0.01B |
|
inf% |
Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.000B |
$0.000B |
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|